The Chief Editors of the European Respiratory Journal (ERJ) have selected their highlights from the June issue. Topics covered include: rituximab and mycophenolate mofetil in patients with ILD; long-term inhaled treprostinil for pulmonary hypertension due to ILD; and e-cigarette vapour-induced lung inflammation. The issue also includes an ERS technical standard that discusses the development of a pan-European standard for comprehensive high-quality lung cancer CT screening. Access the Chief Editors' full list or visit erj.ersjournals.com to browse the ERJ, the most highly regarded peer-reviewed respiratory journal in Europe.
No comments:
Post a Comment